+ Larger Font | + Smaller Font
Share

Welcome to Robin's Social Network

Be part of the community and join us today!

Growth Of Regenerative Medicine Market

The Regenerative Medicine Market is expected to reach USD 38.7 billion by 2024 from USD 13.3 billion in 2019, at a CAGR of 23.8%.

According to the new market research report “Regenerative Medicine Market by Type [Cell-Based Immunotherapy & Cell Therapy (Allogeneic & Autologous Products), Tissue Engineering, Gene Therapy], Applications (Wounds & Dermal, Musculoskeletal, Oncology), Region — Global Forecast to 2024”, published by MarketsandMarkets™.

Growth in this market is largely driven by the introduction of Cures Act for regenerative medicine by FDA, increased funding for regenerative medicine research, development of CAR-T cell therapies and increasing demand for regenerative medicine for the treatment of cancer, orthopedic disorders, and chronic wounds among others.

 

Download PDF Brochure:

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=65442579

Cell-based immunotherapy & cell therapy products segment dominated the Regenerative Medicine Market in 2019.

On the basis of type, the Regenerative Medicine Market is classified into cell-based immunotherapy & cell therapy products, gene therapy products, and tissue-engineered products. The cell-based immunotherapy & cell therapy products segment accounted for the largest market share in 2019 owing to increasing demand for cell-based immunotherapies, the establishment of cures act by FDA to streamline the regenerative medicine approval are the major factors driving the growth of this market segment.

Browse and in-depth TOC on “Regenerative Medicine Market”

76 — Tables

29 — Figures

107 — Pages

Speak to Our Subject Expert:

https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=65442579

Musculoskeletal disorders applications segment likely to dominate the market in 2019.

On the basis of application, the Regenerative Medicine Market is categorized into musculoskeletal disorders, wound care, oncology, ocular disorders, diabetes, and other applications. In 2019, the musculoskeletal disorders segment accounted for the largest market share. The large share of this segment can mainly be attributed to the rising incidence rate of orthopedic diseases with rising geriatric population.

North America anticipated accounting for the largest share of the Regenerative Medicine Market in 2019.

The Regenerative Medicine Market in North America is expected account for the largest share globally, and also grow at a faster rate during the forecast period. Surging research activities in the field of regenerative medicine, introduction of CAR-T cell therapies and growing awareness of personalized medicine have also resulted in the establishment of stem cell banking and tissue engineering.

Request Research Sample Pages:

https://www.marketsandmarkets.com/requestsampleNew.asp?id=65442579

The major players in this market are Kite Pharma (US), Novartis (Switzerland), Vericel Corporation (US), Integra LifeSciences (US), Wright Medical (US), MiMedx (US), Osiris Therapeutics (US), Stryker Corporation (US), and Spark Therapeutics (US). Product launches and acquisitions are the key growth strategies followed by most players in this Regenerative Medicine Market.



on April 4 at 10:00

Comments (0)




Become a member and experience a unique opportunity to post blogs, photos, Youtube Vimeo videos, topics, events, and create groups on Robin's Social Networking Site. Use Robin's Social to sell products, services and market your business when posting blogs.

By registering and posting content, you agree to the terms listed at... Posting Terms and Conditions. Enjoy!

© 2019 Robin's Social Network Content By Members. All Rights Reserved.